The expression of cyclin E in invasive ductal carcinoma of the breast
Chen Tongy
Abstract
Chen Tongy
Abstract
Objective To study the relationship between the expression of cyclin E and prognosis in invasive ductal carcinoma of the breast.Methods 35 cases with invasive ductal carcinoma of the breast were studied for cyclin E expression with immunohistochemical method.Results The high cyclin E expression rate in the patients with invasive ductal carcinoma of the breast was 57.14%,while the low expression rate was 42.86%.High cyclin E expression in invasive ductal carcinoma of the breast was not correlated with tumor size,lymphnode metastasis,but had a high correlation with the prognosis of the patients showed a negative expression of ER and PR.Conclusions Cyclin E expression may be significant in predicting the prognosis of the patients with invasive ductal carcinoma of the breast and in selecting appropriate postoperative adjuvant therapies.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the relationship between the expression of cyclin E and prognosis in invasive ductal carcinoma of the breast.Methods 35 cases with invasive ductal carcinoma of the breast were studied for cyclin E expression with immunohistochemical method.Results The high cyclin E expression rate in the patients with invasive ductal carcinoma of the breast was 57.14%,while the low expression rate was 42.86%.High cyclin E expression in invasive ductal carcinoma of the breast was not correlated with tumor size,lymphnode metastasis,but had a high correlation with the prognosis of the patients showed a negative expression of ER and PR.Conclusions Cyclin E expression may be significant in predicting the prognosis of the patients with invasive ductal carcinoma of the breast and in selecting appropriate postoperative adjuvant therapies.
Key concepts: Immunohistochemistry, Ductal carcinoma, Medicine, Breast carcinoma, Invasive ductal carcinoma, Cyclin E, Oncology, Cyclin D1